Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/2024-513751-32-00
2024-513751-32-00CompletedPhase 4

Bioequivalence of Amoxicillin and Clavulanic Acid 500 mg/125 mg Film-Coated Tablets in Healthy Participants Under Fed Conditions.

Bial Portela & Ca S.A.1 site in 1 country48 target enrollmentStarted: July 11, 2024Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
Phase 4
Status
Completed
Enrollment
48
Locations
1
Study OverviewEligibility CriteriaInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Eligibility Criteria

Ages
18 years to 64 years (18-64 Years)
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Investigators

Sponsor Class
Pharmaceutical company
Responsible Party
Principal Investigator
Principal Investigator

Andreia Guimarães

Scientific

Bial Portela & Ca S.A.

Study Sites (1)

Loading locations...

Similar Trials

Active, not recruiting
Phase 1
Pharmacokinetic of Amoxicillin and Clavulanacid in pneumonic, interstitial lung tissue measured by in vivo microdialysis, in patients with pleural empyema treated by decortication.To measure the time versus concentration profile of Amoxicillin and Clavulanacid in the interstitial space of infected lung tissue as the target site of infection following intravenous administration of Amoxicillin and Clavulanacid
EUCTR2005-003107-36-ATDepartment of Thoracic and Hyperbaric Surgery, University Medical School Graz
Recruiting
Not Applicable
The effect of a common antibiotic (amoxicillin with clavulanate) on the microbiome of tonsil tissue in children with recurrent tonsillitisTonsillitisInfection - Studies of infection and infectious agentsOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon
ACTRN12618001847202The University of Auckland60
Completed
Not Applicable
Treatment of Community Acquired Pneumonia in childre
CTRI/2019/01/017124DR AMRIT AGARWA104
Completed
Phase 1
Bioequivalence Study of an Amoxicillin-ClavulanicInfections, Respiratory Tract
NCT01772238GlaxoSmithKline35
Not yet recruiting
Phase 4
A direct comparison of two intravenous antibiotics for the treatment of diabetic foot infections in adultsDiabetic foot infectionInfection - Other infectious diseasesMetabolic and Endocrine - Diabetes
ACTRN12620000230954Gold Coast Hospital and Health Service484